NaviFUS Corp.

6872 · TWO · Healthcare / Medical Devices

19.30TWD+1.30 (+7.22%)

Price History

Full chart

Market Stats

Previous Close18.00

Open18.00

Day Range18.00 – 19.80

52-Week Range13.80 – 27.05

Volume122.15K

Market Cap1.63B

P/E (TTM)0.00

Forward P/E0.00

EPS-2.16

Dividend Yield0.00%

50-Day Avg18.46

200-Day Avg18.34

About

NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgical tracking technology to monitor the 3D position of the needle tip during ultrasonic interventional procedures. The company was founded in 2015 and is based in Taipei, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEODr. Arthur Lung Ph.D.
Employees0
HeadquartersNo. 246, Chengde Rd., Taipei, Taiwan, 103, Taiwan
Websitehttps://navifus.com

Leadership

Dr. Arthur Lung Ph.D.Chief Executive Officer
Dr. Hao-Li Liu Ph.D.Founder & Chief Technical Consultant

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	19.53M	22.48M	27.53M	10.48M
Growth (%)	-	-	+15.13%	+22.46%	-61.92%
Cost of Revenue	0	3.03M	10.65M	17.85M	13.27M
Gross Profit	0	16.49M	11.83M	9.68M	-2.79M
Gross Margin	-	84.47%	52.61%	35.17%	-26.61%
Operating Expense	82.58M	89.39M	88.25M	120.56M	156.90M
Operating Income	-82.58M	-72.90M	-76.43M	-110.88M	-159.69M
Operating Margin	-	-373.34%	-339.96%	-402.77%	-1523.35%
EBITDA	-	-53.84M	-55.80M	-77.03M	-123.06M
EBITDA Margin	-	-275.73%	-248.19%	-279.81%	-1173.91%
Net Income	-82.80M	-63.59M	-65.73M	-95.13M	-148.46M
Net Income Margin	-	-325.68%	-292.38%	-345.53%	-1416.19%
R&D	55.90M	64.02M	58.93M	84.15M	116.51M
R&D as % of Total Revenue	-	327.87%	262.13%	305.67%	1111.45%
Interest Expense	27.00K	12.00K	429.00K	585.00K	468.00K
Interest Expense % of Total Revenue	-	0.06%	1.91%	2.12%	4.46%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	589.92M	524.07M	490.54M	546.69M	635.99M
Total Liabilities	25.88M	21.19M	53.40M	54.04M	70.61M
Total Equity	546.44M	484.95M	423.00M	481.50M	555.64M
Cash	307.82M	223.63M	155.82M	162.97M	187.77M

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-52.11M	-57.36M	-48.69M	-77.71M	-91.24M
Capital Expenditure	8.64M	24.22M	39.45M	56.15M	47.61M
Free Cash Flow	-60.76M	-81.58M	-88.14M	-133.87M	-138.85M
FCF to OCF	116.59%	142.23%	181.01%	172.26%	152.18%

Key Statistics & Ratios

Market Cap1.63B

Enterprise Value1.28B

Trailing P/E0.00

Forward P/E0.00

Price / Sales60.23

Price / Book3.38

EPS-2.16

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding70.75M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%